Press-release for stocks for AZN

| -3.47% | O: -1.71% H: 0.22% C: -1.8%
AZN | News | $59.69 |

| 0.59% | O: 0.59% H: 0.0% C: 0.0%
GSK | News | $45.96 |

| -0.84% | O: -0.84% H: 0.0% C: 0.0%
AZNCF | News | $119.67 |

| 0.56% | O: -0.26% H: 0.83% C: 0.83%
ABT | News | $126.83 |

| -0.7% | O: -0.7% H: 0.0% C: 0.0%
treatment report

ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Published: 2022-01-17 (Crawled : 09:00) - biospace.com/
AZN | News | $59.69 |

enhertu granted positive cancer breast cancer

Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $119.67 |

| 2.11% | O: -0.21% H: 0.98% C: 0.98%
INCY | $74.78 |

| 1.53% | O: 0.0% H: 0.0% C: 0.0%
ONCY | News | $1.55 |

| 0.65% | O: 0.65% H: 0.0% C: 0.0%
AZN | News | $59.69 |

| 2.74% | O: 0.17% H: 0.0% C: 0.0%
PFE | News | $53.68 |

| -3.35% | O: -1.01% H: 0.0% C: 0.0%
treatment cancer breast cancer merge

PD-1 And PD-L1 Inhibitors Market to Grow by USD 29.97 billion| Reduction in Cancer Mortality Rate to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-01-13 (Crawled : 11:00) - prnewswire.com
AGEN | $2.84 |

| -7.49% | O: -2.28% H: 1.67% C: -3.67%
AZN | News | $59.69 |

| 2.74% | O: 1.0% H: 0.02% C: -0.99%
AMGN | News | $233.74 |

| 0.57% | O: -0.15% H: 0.0% C: 0.0%
AZNCF | News | $119.67 |

| 3.77% | O: 2.17% H: 0.07% C: -0.53%
research cancer growth

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update
Published: 2022-01-12 (Crawled : 14:00) - globenewswire.com
AZN | News | $59.69 |

| 4.46% | O: 1.68% H: 0.0% C: 0.0%
ARTL | $0.4349 |

| -7.21% | O: 0.28% H: 2.47% C: 1.13%
AZNCF | News | $119.67 |

| 3.6% | O: 0.0% H: 0.76% C: -0.16%

Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE | News | $53.68 |

AZNCF | News | $119.67 |

SNYNF | News | $104.92 |

TAK | $14.52 |

SNY | News | $51.79 |

LLY | $245.05 |

GLAXF | News | $22.5865 |

GSK | News | $45.96 |

AZN | News | $59.69 |

JNJ | News | $167.165 |

drug depression

Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics
Published: 2022-01-05 (Crawled : 12:30) - prnewswire.com
AZN | News | $59.69 |

| 4.43% | O: 0.16% H: 0.0% C: 0.0%
CNTX | $2.07 |

| -24.45% | O: -1.46% H: 3.33% C: -7.78%
partnership era therapeutics molecular antibody platform

| 3.47% | O: 1.48% H: 0.0% C: -3.3%
AZN | News | $59.69 |

| 4.43% | O: 0.16% H: 0.0% C: 0.0%
cancer growth

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Published: 2022-01-03 (Crawled : 15:00) - biospace.com/
AZNCF | News | $119.67 |

| 3.3% | O: 2.49% H: 1.06% C: -2.49%
GNPX | $2.08 |

| 58.78% | O: 16.79% H: 0.0% C: 0.0%
AZN | News | $59.69 |

| 2.47% | O: 0.03% H: 0.17% C: 0.07%
keytruda fast track designation treatment fda fast track gene therapy era cel fda fast track lung cancer therapy cancer

DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Published: 2021-12-23 (Crawled : 14:00) - biospace.com/
AZN | News | $59.69 |

| 2.77% | O: -1.0% H: 0.71% C: 0.24%
enhertu trial cel lung cancer cancer phase 3 initiated

Fortress Biotech to Ring Nasdaq Stock Market Closing Bell on December 21
Published: 2021-12-21 (Crawled : 01:00) - globenewswire.com
AZN | News | $59.69 |

| 5.53% | O: 0.19% H: 0.94% C: 0.48%
FBIO | $2.1 |

| -19.54% | O: 1.92% H: 2.26% C: -0.38%
AZNCF | News | $119.67 |

| 9.23% | O: 3.52% H: 2.27% C: 2.27%
nasdaq biotech iot

EnWave Reports Fourth Quarter and Annual 2021 Consolidated Financial Results
Published: 2021-12-16 (Crawled : 14:00) - globenewswire.com
AZN | News | $59.69 |

| 8.63% | O: 2.13% H: 1.9% C: 1.73%
BRID | $12.12 |

| 2.62% | O: -1.52% H: 0.0% C: 0.0%
financial results results

Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
FBIO | $2.1 |

| -18.29% | O: 1.95% H: 0.0% C: -5.34%
AZNCF | News | $119.67 |

| 8.46% | O: 1.5% H: 1.71% C: 1.71%
AZN | News | $59.69 |

| 8.63% | O: 2.13% H: 1.9% C: 1.73%
phase 2 ces trial biotech iot hiv

Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform
Published: 2021-12-15 (Crawled : 08:00) - biospace.com/
AZN | News | $59.69 |

| 9.56% | O: 0.86% H: 0.0% C: 0.0%
ces era license platform

Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published: 2021-12-14 (Crawled : 17:00) - prnewswire.com
TRUMF | $36.864 |

| -12.94% | O: -1.42% H: 0.02% C: 0.02%
MDT | News | $107.38 |

| -4.54% | O: -0.2% H: 0.66% C: -0.52%
BDX | News | $260.99 |

| 3.24% | O: -0.3% H: 0.1% C: -1.63%
SNY | News | $51.79 |

| 6.56% | O: -0.51% H: 0.0% C: 0.0%
AZN | News | $59.69 |

| 9.93% | O: 0.33% H: 0.0% C: 0.0%
ATRS | $3.42 |

| 6.54% | O: -0.31% H: 0.7% C: -0.63%
TRUMY | $36.43 |

| -12.15% | O: -1.37% H: 0.68% C: 0.37%
NVO | $97.08 |

| -15.87% | O: -1.8% H: 0.08% C: -0.43%
AZNCF | News | $119.67 |

| 11.55% | O: -1.44% H: 5.82% C: 1.91%
LLY | $245.05 |

| -0.27% | O: 0.82% H: 0.92% C: 0.66%
PODD | $242.71 |

| -8.27% | O: -0.82% H: 0.38% C: -2.71%
ENDP | $3.35 |

| -25.72% | O: -5.76% H: 7.53% C: 0.47%
SNYNF | News | $104.92 |

| 7.48% | O: -3.62% H: 0.0% C: -0.56%
JNJ | News | $167.165 |

| 1.26% | O: 1.9% H: 0.0% C: 0.0%
BMY | $64.72 |

| 13.05% | O: 2.71% H: 2.77% C: 1.21%
drug liver growing drug delivery

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
Published: 2021-12-14 (Crawled : 07:00) - biospace.com/
AZN | News | $59.69 |

| 9.93% | O: 0.33% H: 0.0% C: 0.0%
covid-19 partnership era covid therapy cancer

ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast Cancer
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
AZN | News | $59.69 |

| 8.27% | O: 0.27% H: 0.63% C: -0.58%
enhertu positive cancer breast cancer

Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | News | $119.67 |

| 7.88% | O: 0.41% H: 0.0% C: -2.48%
FBIO | $2.1 |

| -13.58% | O: 7.0% H: 0.0% C: 0.0%
AZN | News | $59.69 |

| 7.94% | O: -2.08% H: 1.18% C: 1.13%
new drug treatment application era drug therapeutics disease biotech iot submission

DESTINY-Breast11 Neoadjuvant Phase 3 Trial of ENHERTU® Initiated in Patients with High-Risk HER2 Positive Early-Stage Breast Cancer
Published: 2021-11-30 (Crawled : 14:30) - biospace.com/
AZN | News | $59.69 |

| 7.18% | O: -0.7% H: 0.0% C: 0.0%
risk trial positive cancer phase 3 breast cancer initiated

Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
Published: 2021-11-29 (Crawled : 17:00) - globenewswire.com
AZNCF | News | $119.67 |

| 6.51% | O: -0.0% H: 0.0% C: 0.0%
AZN | News | $59.69 |

| 5.5% | O: -1.57% H: 0.0% C: 0.0%
ARTL | $0.4349 |

| -38.82% | O: 5.5% H: 0.0% C: -11.8%
financial results bioscience results

← Previous
1
2
3
4
5
6
7
8
9
10
Next →

Your saved searches

Save your searches and get alerts when important news are released.

Mentioned Today

AAL | News | $17.9 |

Transportation

ABB | News | $37.36 |

ABLZF | News | $36.97 |

ACN | News | $348.28 |

ADCT | News | $16.94 |

AG | News | $10.54 |

ALSMY | News | $3.8 |

AMGN | News | $233.74 |

AMH | News | $41.76 |

AMNB | News | $37.42 |

AOMFF | News | $38.01 |

APLS | News | $37.75 |

APM | News | $1.22 |

ARGX | News | $278.72 |

ARMK | News | $34.49 |

ARVL | News | $6.16 |

ASPC | News | $9.87 |

ATLCY | News | $54.315 |

ATLKF | News | $62.5 |

ATLKY | News | $63.04 |

ATRX | News | $0.11 |

ATTLF | News | $54.0 |

ATVI | News | $82.61 |

Consumer Durables

AVGO | News | $563.97 |

AWRE | News | $3.08 |

BAK | News | $18.03 |

BANX | News | $21.6 |

Miscellaneous

BAX | News | $85.99 |

BCOR | News | $16.42 |

BDPT | News | $0.008 |

BFC | News | $71.05 |

BGNE | News | $238.55 |

BHC | News | $25.58 |

BIVI | News | $4.63 |

BLNK | News | $23.34 |

BNGO | News | $2.38 |

BNPQF | News | $73.73 |

BNPQY | News | $36.93 |

Finance and Insurance

BNPZY | News | $ |

Finance and Insurance

BPMC | News | $72.51 |

CAJFF | News | $24.51 |

CASI | News | $0.6909 |

CDE | News | $5.44 |

CDNA | News | $37.46 |

CHRA | News | $5.66 |

Industrial Services

CMS | News | $63.44 |

CNY | News | $ |

COLB | News | $36.03 |

COUR | News | $20.49 |

Educational Services

COWN | News | $31.86 |

CRL | News | $336.68 |

CRON | News | $3.71 |

CRS | News | $31.2 |

CRWD | News | $175.71 |

CSBR | News | $7.91 |

CSCO | News | $57.995 |

CSII | News | $17.73 |

CUE | News | $9.08 |

DATS | News | $2.99 |

DCT | News | $26.55 |

DELL | News | $59.63 |

DEO | News | $204.05 |

DGEAF | News | $50.13 |

DLPN | News | $6.47 |

DNAC | News | $9.84 |

DNZOF | News | $82.25 |

DNZOY | News | $40.75 |

DPZ | News | $469.39 |

DRE | News | $59.67 |

DXC | News | $32.01 |

DYNT | News | $0.9229 |

EXPR | News | $3.03 |

Retail Trade

FBNC | News | $46.15 |

FEYE | News | $17.58 |

FIT | News | $6.93 |

Consumer Durables

FLMN | News | $5.02 |

FLNT | News | $1.68 |

FNCTF | News | $11.19 |

FOUN | News | $9.96 |

FPRX | News | $38.0 |

FRBA | News | $14.1 |

FRBK | News | $3.7 |

FTV | News | $72.24 |

GE | News | $100.62 |

GFED | News | $34.43 |

GIB | News | $84.87 |

GLAXF | News | $22.5865 |

GLNG | News | $13.63 |

Transportation

GNSS | News | $3.94 |

Consumer Durables

GOOG | News | $2739.66 |

GOOGL | News | $2729.61 |

GRMN | News | $131.23 |

GSK | News | $45.96 |

HCCC | News | $9.92 |

HCM | News | $30.98 |

HL | News | $5.78 |

HOLX | News | $70.42 |

HOMB | News | $24.87 |

HON | News | $213.99 |

HSBI | News | $26.3 |

Finance and Insurance

HTHT | News | $34.8 |

HTLD | News | $15.83 |

Transportation

HUBS | News | $455.465 |

IFNNF | News | $42.95 |

IFNNY | News | $43.05 |

IGXT | News | $0.348 |

INFY | News | $24.47 |

INR | News | $ |

INTC | News | $54.65 |

IR | News | $58.38 |

IRMD | News | $39.82 |

JG | News | $0.9321 |

JNJ | News | $167.165 |

JNPR | News | $33.57 |

JPM | News | $148.93 |

JRJC | News | $6.44 |

JUPW | News | $0.7398 |

KMB | News | $142.68 |

LAWS | News | $49.01 |

Distribution Services

LBPS | News | $4.35 |

LCLP | News | $0.018 |

Information

LMT | News | $369.58 |

Mining, Quarrying, and Oil and ...

LTUM | News | $0.273 |

LUMN | News | $12.34 |

LVMHF | News | $778.05 |

LVMUY | News | $155.11 |

MAGOF | News | $ |

MAGOY | News | $ |

MAOGY | News | $ |

MBRX | News | $1.71 |

MCFE | News | $25.645 |

MIME | News | $79.79 |

MLPY | News | $ |

MMX | News | $4.63 |

MOTS | News | $0.459 |

MPLN | News | $3.97 |

MPVDF | News | $0.5966 |

MRK | News | $80.98 |

MRLN | News | $23.5 |

MS | News | $98.0 |

MSFT | News | $306.37 |

MUX | News | $0.94 |

NBY | News | $0.3438 |

NCSYF | News | $279.5 |

NEE | News | $81.17 |

NET | News | $94.67 |

NICE | News | $258.12 |

NKSH | News | $36.25 |

NLOK | News | $26.88 |

NUVB | News | $6.01 |

NVNO | News | $6.4 |

OCFT | News | $2.27 |

OLN | News | $53.42 |

ONCY | News | $1.55 |

OPRA | News | $6.69 |

PANW | News | $499.11 |

PHG | News | $33.99 |

PPL | News | $29.97 |

PPLN | News | $ |

PSORF | News | $7.9559 |

PSX | News | $86.67 |

PTC | News | $117.85 |

QCRH | News | $61.76 |

RELX | News | $30.28 |

RLXXF | News | $30.03 |

RMED | News | $1.375 |

RYDAF | News | $24.9 |

RYDBF | News | $25.11 |

RYLPF | News | $34.16 |

SAP | News | $137.24 |

SAPGF | News | $137.96 |

SASR | News | $51.62 |

SBNY | News | $365.39 |

SEKEF | News | $16.912 |

SEKEY | News | $8.75 |

Health Care and Social Assistan...

SHLX | News | $13.09 |

Industrial Services

SHRG | News | $0.065 |

Information

SING | News | $0.086 |

SLHG | News | $1.0 |

SLNH | News | $10.24 |

SNAP | News | $36.03 |

SNOW | News | $288.01 |

SNY | News | $51.79 |

SNYNF | News | $104.92 |

SPH | News | $15.44 |

STRR | News | $1.785 |

STZ | News | $243.32 |

SYIEF | News | $129.68 |

SYIEY | News | $32.32 |

SYK | News | $258.3 |

TEL | News | $159.9 |

TGNA | News | $20.19 |

TKAT | News | $3.24 |

TMQ | News | $1.67 |

TOT | News | $48.3 |

TRI | News | $107.7 |

TRU | News | $104.12 |

TWST | News | $55.21 |

UCBJF | News | $110.49 |

UCBJY | News | $51.73 |

UMPQ | News | $21.065 |

URR | News | $ |

UUUU | News | $6.79 |

VEEV | News | $220.13 |

VHAQ | News | $10.04 |

VLON | News | $5.45 |

VRTX | News | $230.84 |

VSAT | News | $45.04 |

VTSI | News | $6.44 |

VZ | News | $53.5 |

WIMI | News | $3.0 |

Professional, Scientific, and T...

XLO | News | $14.0 |

XRTX | News | $1.77 |

Mining, Quarrying, and Oil and ...

XRTXF | News | $ |

XYF | News | $2.83 |

ZEAL | News | $21.22 |

ZGNX | News | $26.05 |

ZNTE | News | $10.17 |

ZYXI | News | $8.42 |